Clinical Trials for Alentis Therapeutics

Explore 3 clinical trials worldwide

Showing 1-3 of 3 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Alentis Therapeutics

Clinical Trials (3)

NCT07169734
A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors
PHASE1/PHASE2Recruiting
180 participants
Started: Aug 26, 2025 · Completed: Oct 4, 2029
5 conditions1 sponsor2 locations
NCT06747585
A Study to Investigate ALE.P02 as Monotherapy in Adult Patients With Selected CLDN1+ Solid Tumors
PHASE1/PHASE2Recruiting
170 participants
Started: Dec 16, 2024 · Completed: Aug 15, 2028
4 conditions1 sponsor30 locations
NCT06047171
Rescue of Nephrons With ALE.F02 (RENAL-F02)
PHASE2Recruiting
80 participants
Started: Sep 7, 2023 · Completed: Jun 30, 2027
1 condition1 sponsor48 locations